Hoffman E, Mladsi DM, Cryer B, Hopkins W, Brater DC, Parikh R, Goyal R, Castellsague J, Stafkey-Mailey D, Young C. Dose-related risks of cardiovascular, gastrointestinal, and renal adverse events associated with meloxicam among patients with osteoarthritis: an observational study using US claims data. Poster presented at the 2016 ACR/ARHP Annual Meeting; November 15, 2016. Washington, DC. [abstract] Arthritis Rheumatol. 2016 Sep 28; 68(Suppl 10).
Purser MF, Mladsi DM, Wolowacz SE. A review of NICE technology appraisals using single-arm trials. Poster presented at the 2014 ISPOR 19th Annual International Meeting; June 3, 2014. Montreal, Canada.
Herring WL, Mladsi D, Mauskopf J. Patient-level simulation modeling for economic evaluations: opportunities and challenges in a practical setting. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 1, 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):A28-9.
Herring WL, Mladsi DM, Miles L, Ronquest N. A novel approach to ranking parameter uncertainty in one-way sensitivity analysis: what tornado diagrams are missing. Poster presented at the 2013 ISPOR 18th Annual International Meeting; May 1, 2013. New Orleans, LA. [abstract] Value Health. 2013 May; 16(3):A20.
Redekop WK, Mladsi D. The faces of personalized medicine: a framework for understanding its meaning and scope. Value Health. 2013;16(Suppl 6):S4-9. doi: 10.1016/j.jval.2013.06.005.
Mladsi DM, Graham JB, Ronquest NA. Trade-off analysis: an extension of threshold pricing analysis. Poster presented at the 2012 ISPOR 17th Annual International Meeting; June 7, 2012. Washington, DC. [abstract] Value Health. 2012 Jun; 15(4):A169.
Mladsi D, Herring WL, Earnshaw S. Cost-effectiveness analysis in personalized medicine: general hypotheses and corresponding decision tree structures for screening, diagnostic, predictive, prognostic, surveillance, and monitoring tests. Poster presented at the 2012 ISPOR 17th Annual International Meeting; June 7, 2012. Washington, DC. [abstract] Value Health. 2012 Jun; 15(4):A168-9.
Mladsi DM, Redekop K, Goettsch A, Earnshaw SR. Challenges and insights in establishing and communicating the economic value of companion diagnostics. Presented at the 2010 ISPOR 13th Annual European Congress; November 2010. Prague, Czech Republic.
Mladsi D, Earnshaw S, Ronquest NA, Keith M. The threshold pricing model: not just another cost-effectiveness model. Poster presented at the 2010 ISPOR 13th Annual European Congress; November 15, 2010. Prague, Czech Republic. [abstract] Value Health. 2010 Nov; 13(7):A332.
Mladsi D, Earnshaw S, Akashi-Ronquest N, Keith M. Proposed methods for conducting sensitivity analyses on threshold-derived estimates of value-based price and product profiles of early stage drugs. Poster presented at the 2010 ISPOR 13th Annual European Congress; November 15, 2010. Prague, Czech Republic. [abstract] Value Health. 2010 Nov; 13(7):A333.
Odom DM, Bennett L, Irish W, Mladsi DM. Statistical methods to handle incomplete longitudinal patient-reported outcomes data in advanced disease stage trials. Presented at the 2009 ISPOR 12th Annual European Congress; October 2009. Paris, France.
Mladsi D, de Cambra S, Gilabert-Perramon A, Faulkner EC. Orphan drug funding: a model for personalized medicine? Presented at the 2009 ISPOR 12th Annual European Congress; October 2009. Paris, France.
de Cambra S, Mladsi D, Neale S. International payer research: comparing and contrasting payer roles and research methods in Canada, Spain, and the UK. Poster presented at the 2009 ISPOR 12th Annual European Congress; October 28, 2009. Paris, France. [abstract] Value Health. 2009 Oct; 12(7):A245. doi: 10.1111/j.1524-4733.2009.00592_1.x
Mladsi DM, Palmer WN, Miller D. Threshold pricing analysis: an economist's contribution to pharmaceutical pricing. Presented at the 2008 ISPOR 11th Annual European Congress; November 2008. Athens, Greece.
Mladsi DM. MMA Part D: how has the US market changed? Presented at the Visiongain 4th Annual Pricing and Reimbursement Conference; May 26, 2006. London, UK.
Mladsi DM. Developing health economic models for assessing cost-effectiveness and product value. Presented at the 2006 Health Economics Conference; April 28, 2006. London, UK.
Gregson N, Sparrowhawk K, Mladsi DM. Global pricing and reimbursement strategy: an integrated analytical framework. Presented at the 2005 ISPOR 8th Annual European Congress; November 8, 2005. Florence, Italy.
Johnson FR, Mladsi DM, Sparrowhawk K. Conjoint analysis: application to global pricing and reimbursement strategy. Presented at the 2005 ISPOR 8th Annual European Congress; November 7, 2005. Florence, Italy.
Lucero MA, Mladsi D, Mauskopf J. Communicating the value: developing messages for payers. Presented at the 2004 ISPOR 7th Annual European Congress; October 24, 2004. Hamburg, Germany.
West R, Curry SJ, Fiore MC, Sullivan SD, Neighbors D, Gilsenan AW, Smadja E, Lavaud V. Attempt cohort: weight gain concern of smokers intending to quit. Poster presented at the 10th Annual Scientific Sessions of the Society for Research on Nicotine and Tobacco; February 2004. Scottsdale, AZ.
Ortiz M, Neighbors DM. Collecting evidence of equivalence: implications for economic analyses. Presented at the 2002 ISPOR 7th Annual International Meeting; May 19, 2002. Arlington, VA.
Irish WD, Neighbors D, Ortiz M. Evaluating therapeutic equivalence using meta analysis: implications for economic analysis. Poster presented at the Symposium on Meta Analysis of Medical Data sponsored by Mathematical Sciences Research Institute; 2002. Berkeley, CA.
Irish WD, Neighbors DM, Lopez RB. Using propensity scores to adjust for treatment selection bias: review of methods plus an extension for use in studies with three or more treatment groups. Presented at the 2001 ISPOR 4th Annual European Congress; November 11, 2001. Cannes, France.
Neighbors DM, Candrilli SD. Concomitant medication costing using clinical trial data: a case study. Presented at the 2000 ISPOR 5th Annual International Meeting; May 2000. Arlington, VA.
Neighbors DM. Potential for bias when using clinical trial adverse event rates to estimate toxicity costs. Presented at the 1999 ISPOR 2nd Annual European Congress; November 1999. Edinburgh, Scotland.
Neighbors DM, Downs KE. Medical resource use data collection in clinical trials. Presented at the DIA Meeting Session Economic Assessment in Clinical Trials: Design and Analysis; November 1999. Orlando, FL.
Neighbors D. Development and use of interactive drug value models. Presented at the UNC School of Pharmacy; 1994. Chapel Hill, NC.
Neighbors D, Mauskopf JA. Importance of quality of life and cost-effectiveness studies in new drug development. Presented at the Southeast Regional Meeting of the American Association of Pharmaceutical Scientists; 1994. Research Triangle Park, NC.
French M, Neighbors D, Carswell L, Williams R, Bush L. A model for estimating industry compliance costs of food labeling regulations. Agribusiness: An International Journal. 1993;8(2):165-86.
French M, Neighbors D. A model to estimate the compliance costs of food labeling regulations. In: J.A. Caswell, editors. The economics of food safety. New York: United States. New York: Elsevier Science Publishing Co, Inc; 1991. p.299-325.